GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS

Clinical trials for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS explained in plain language.

Never miss a new study

Get alerted when new GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS trials appear

Sign up with your email to follow new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Targeted radiation therapy tested in teens with rare cancers

Disease control Ongoing

This study is testing the safety and measuring the radiation dose of a drug called Lutathera in teenagers (ages 12 to 18) with specific rare tumors. Lutathera is a targeted radiation therapy that seeks out and delivers radiation to tumor cells. The main goals are to see how much …

Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS

Phase: PHASE2 • Sponsor: Advanced Accelerator Applications • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS

Get alerted when new GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS trials appear

Targeted radiation therapy tested in teens with rare cancers